|
1
|
Galicia-Garcia U, Benito-Vicente A, Jebari
S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H and Martín C:
Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci.
21:62752020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng Y, Ley SH and Hu FB: Global
aetiology and epidemiology of type 2 diabetes mellitus and its
complications. Nat Rev Endocrinol. 14:88–98. 2018. View Article : Google Scholar
|
|
3
|
Demir S, Nawroth PP, Herzig S and Ekim
Üstünel B: Emerging targets in type 2 diabetes and diabetic
complications. Adv Sci (Weinh). 8:21002752021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Everett E and Mathioudakis N: Update on
management of diabetic foot ulcers:. Ann N Y Acad Sci.
1411:153–165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wolf SJ, Melvin WJ and Gallagher K:
Macrophage-mediated inflammation in diabetic wound repair. Semin
Cell Dev Biol. 119:111–118. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gomez-Larrauri A, Presa N,
Dominguez-Herrera A, Ouro A, Trueba M and Gomez-Muñoz A: Role of
bioactive sphingolipids in physiology and pathology. Essays
Biochem. 64:579–589. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Castro BM, Prieto M and Silva LC:
Ceramide: A simple sphingolipid with unique biophysical properties.
Prog Lipid Res. 54:53–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Summers SA: Editorial: The role of
ceramides in diabetes and cardiovascular disease. Front Endocrinol
(Lausanne). 12:6678852021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Raichur S, Brunner B, Bielohuby M, Hansen
G, Pfenninger A, Wang B, Bruning JC, Larsen PJ and Tennagels N: The
role of C16:0 ceramide in the development of obesity and type 2
diabetes: CerS6 inhibition as a novel therapeutic approach. Mol
Metab. 21:36–50. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Field BC, Gordillo R and Scherer PE: The
role of ceramides in diabetes and cardiovascular disease regulation
of ceramides by adipokines. Front Endocrinol (Lausanne).
11:5692502020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lechner A, Akdeniz M, Tomova-Simitchieva
T, Bobbert T, Moga A, Lachmann N, Blume-Peytavi U and Kottner J:
Comparing skin characteristics and molecular markers of xerotic
foot skin between diabetic and non-diabetic subjects: An
exploratory study. J Tissue Viability. 28:200–209. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Summers SA, Chaurasia B and Holland WL:
Metabolic messengers: Ceramides. Nat Metab. 1:1051–1058. 2019.
View Article : Google Scholar
|
|
13
|
Custodia A, Aramburu-Núñez M, Correa-Paz
C, Posado-Fernández A, Gómez-Larrauri A, Castillo J, Gómez-Muñoz A,
Sobrino T and Ouro A: Ceramide metabolism and Parkinson's
disease-therapeutic targets. Biomolecules. 11:9452021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alexandropoulou I, Grammatikopoulou MG,
Gkouskou KK, Pritsa AA, Vassilakou T, Rigopoulou E, Lindqvist HM
and Bogdanos DP: Ceramides in autoimmune rheumatic diseases:
Existing evidence and therapeutic considerations for diet as an
anticeramide treatment. Nutrients. 15:2292023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mandell EW and Savani RC: Ceramides,
autophagy, and apoptosis mechanisms of ventilator-induced lung
injury and potential therapeutic targets. Am J Respir Crit Care
Med. 199:687–689. 2019. View Article : Google Scholar :
|
|
16
|
Pal P, Atilla-Gokcumen GE and Frasor J:
Emerging roles of ceramides in breast cancer biology and therapy.
Int J Mol Sci. 23:111782022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wattenberg BW: The long and the short of
ceramides. J Biol Chem. 293:9922–9923. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cha HJ, He C, Zhao H, Dong Y, An IS and An
S: Intercellular and intracellular functions of ceramides and their
metabolites in skin (Review). Int J Mol Med. 38:16–22. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Magnan C and Le Stunff H: Role of
hypothalamic de novo ceramides synthesis in obesity and associated
metabolic disorders. Mol Metab. 53:1012982021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Insausti-Urkia N, Solsona-Vilarrasa E,
Garcia-Ruiz C and Fernandez-Checa JC: Sphingomyelinases and liver
diseases. Biomolecules. 10:14972020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Taniguchi M and Okazaki T: Role of
ceramide/sphingomyelin (SM) balance regulated through 'SM cycle' in
cancer. Cell Signal. 87:1101192021. View Article : Google Scholar
|
|
22
|
Hammerschmidt P and Brüning JC:
Contribution of specific ceramides to obesity-associated metabolic
diseases. Cell Mol Life Sci. 79:3952022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bhattacharya N, Sato WJ, Kelly A,
Ganguli-Indra G and Indra AK: Epidermal lipids: Key mediators of
atopic dermatitis pathogenesis. Trends Mol Med. 25:551–562. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roszczyc-Owsiejczuk K and Zabielski P:
Sphingolipids as a culprit of mitochondrial dysfunction in insulin
resistance and type 2 diabetes. Front Endocrinol (Lausanne).
12:6351752021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aldoghachi AF, Baharudin A, Ahmad U, Chan
SC, Ong TA, Yunus R, Razack AH, Yusoff K and Veerakumarasivam A:
Evaluation of CERS2 gene as a potential biomarker for bladder
cancer. Dis Markers. 2019:38751472019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Polubothu S, Glover M, Holder SE and
Kinsler VA: Uniparental disomy as a mechanism for CERS3-mutated
autosomal recessive congenital ichthyosis. Br J Dermatol.
179:1214–1215. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sheridan M and Ogretmen B: The role of
ceramide metabolism and signaling in the regulation of mitophagy
and cancer therapy. Cancers (Basel). 13:24752021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kurz J, Parnham MJ, Geisslinger G and
Schiffmann S: Ceramides as novel disease biomarkers. Trends Mol
Med. 25:20–32. 2019. View Article : Google Scholar
|
|
29
|
Mullen TD, Hannun YA and Obeid LM:
Ceramide synthases at the centre of sphingolipid metabolism and
biology. Biochem J. 441:789–802. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Parveen F, Bender D, Law SH, Mishra VK,
Chen CC and Ke LY: Role of ceramidases in sphingolipid metabolism
and human diseases. Cells. 8:15732019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Q, Fang H, Dang E and Wang G: The role
of ceramides in skin homeostasis and inflammatory skin diseases. J
Dermatol Sci. 97:2–8. 2020. View Article : Google Scholar
|
|
32
|
Jung K, Kim SH, Joo KM, Lim SH, Shin JH,
Roh J, Kim E, Park W and Kim W: Oral intake of enzymatically
decomposed AP collagen peptides improves skin moisture and ceramide
and natural moisturizing factor contents in the stratum corneum.
Nutrients. 13:43722021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ramírez-Vélez R, Martínez-Velilla N,
Correa-Rodríguez M, Sáez de Asteasu ML, Zambom-Ferraresi F,
Palomino-Echeverria S, García-Hermoso A and Izquierdo M: Lipidomic
signatures from physically frail and robust older adults at
hospital admission. Geroscience. 44:1677–1688. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Coderch L, López O, de la Maza A and Parra
JL: Ceramides and skin function. Am J Clin Dermatol. 4:107–129.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Badhe Y, Gupta R and Rai B: Structural and
barrier properties of the skin ceramide lipid bilayer: A molecular
dynamics simulation study. J Mol Model. 25:1402019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vollmer DL, West VA and Lephart ED:
Enhancing skin health: By oral administration of natural compounds
and minerals with implications to the dermal microbiome. Int J Mol
Sci. 19:30592018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim B, Shon JC, Seo HS, Liu KH, Lee JW,
Ahn SK and Hong SP: Decrease of ceramides with long-chain fatty
acids in psoriasis: Possible inhibitory effect of interferon gamma
on chain elongation. Exp Dermatol. 31:122–132. 2022. View Article : Google Scholar
|
|
38
|
Wang L, Liu M, Ning D, Zhu H, Shan G, Wang
D, Ping B, Yu Y, Yang H, Yan K, et al: Low serum ZAG levels
correlate with determinants of the metabolic syndrome in Chinese
subjects. Front Endocrinol (Lausanne). 11:1542020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fujiwara A, Morifuji M, Kitade M, Kawahata
K, Fukasawa T, Yamaji T, Itoh H and Kawashima M: Age-related and
seasonal changes in covalently bound ceramide content in forearm
stratum corneum of Japanese subjects: Determination of molecular
species of ceramides. Arch Dermatol Res. 310:729–735. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Łuczaj W, Jastrząb A, do Rosário Domingues
M, Domingues P and Skrzydlewska E: Changes in phospholipid/ceramide
profiles and eicosanoid levels in the plasma of rats irradiated
with UV rays and treated topically with cannabidiol. Int J Mol Sci.
22:87002021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fujii M: The pathogenic and therapeutic
implications of ceramide abnormalities in atopic dermatitis. Cells.
10:23862021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meckfessel MH and Brandt S: The structure,
function, and importance of ceramides in skin and their use as
therapeutic agents in skin-care products. J Am Acad Dermatol.
71:177–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Draelos ZD: The science behind skin care:
Moisturizers. J Cosmet Dermatol. 17:138–144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wertz PW: Roles of lipids in the
permeability barriers of skin and oral mucosa. Int J Mol Sci.
22:52292021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bocheńska K and Gabig-Cimińska M:
Unbalanced sphingolipid metabolism and its implications for the
pathogenesis of psoriasis. Molecules. 25:11302020. View Article : Google Scholar
|
|
46
|
Santinha DR, Marques DR, Maciel EA, Simões
CS, Rosa S, Neves BM, Macedo B, Domingues P, Cruz MT and Domingues
MR: Profiling changes triggered during maturation of dendritic
cells: A lipidomic approach. Anal Bioanal Chem. 403:457–471. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Paget C, Deng S, Soulard D, Priestman DA,
Speca S, von Gerichten J, Speak AO, Saroha A, Pewzner-Jung Y,
Futerman AH, et al: TLR9-mediated dendritic cell activation
uncovers mammalian ganglioside species with specific ceramide
backbones that activate invariant natural killer T cells. PLoS
Biol. 17:e30001692019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Scheiblich H, Schlütter A, Golenbock DT,
Latz E, Martinez-Martinez P and Heneka MT: Activation of the NLRP3
inflammasome in microglia: The role of ceramide. J Neurochem.
143:534–550. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zheng Y, Hunt RL, Villaruz AE, Fisher EL,
Liu R, Liu Q, Cheung GYC, Li M and Otto M: Commensal staphylococcus
epidermidis contributes to skin barrier homeostasis by generating
protective ceramides. Cell Host Microbe. 30:301–313.e9. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Y, Shao T, Wang J, Huang X, Deng X,
Cao Y, Zhou M and Zhao C: An update on potential biomarkers for
diagnosing diabetic foot ulcer at early stage. Biomed Pharmacother.
133:1109912021. View Article : Google Scholar
|
|
51
|
Abbott CA, Chatwin KE, Foden P, Hasan AN,
Sange C, Rajbhandari SM, Reddy PN, Vileikyte L, Bowling FL, Boulton
AJM and Reeves ND: Innovative intelligent insole system reduces
diabetic foot ulcer recurrence at plantar sites: A prospective,
randomised, proof-of-concept study. Lancet Digit Health.
1:e308–e318. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kim EJ and Han K: Factors related to
self-care behaviours among patients with diabetic foot ulcers. J
Clin Nurs. 29:1712–1722. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bandyk DF: The diabetic foot:
Pathophysiology, evaluation, and treatment. Semin Vasc Surg.
31:43–48. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Aldana PC, Cartron AM and Khachemoune A:
Reappraising diabetic foot ulcers: A focus on mechanisms of
ulceration and clinical evaluation. Int J Low Extrem Wounds.
21:294–302. 2022. View Article : Google Scholar
|
|
55
|
Rubitschung K, Sherwood A, Crisologo AP,
Bhavan K, Haley RW, Wukich DK, Castellino L, Hwang H, La Fontaine
J, Chhabra A, et al: Pathophysiology and molecular imaging of
diabetic foot infections. Int J Mol Sci. 22:115522021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Armstrong DG, Boulton AJM and Bus SA:
Diabetic foot ulcers and their recurrence. N Engl J Med.
376:2367–2375. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Feldman EL, Callaghan BC, Pop-Busui R,
Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW and
Viswanathan V: Diabetic neuropathy. Nat Rev Dis Primers. 5:422019.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Volpe CMO, Villar-Delfino PH, dos Anjos
PMF and Nogueira-Machado JA: Cellular death, reactive oxygen
species (ROS) and diabetic complications. Cell Death Dis.
9:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bönhof GJ, Herder C, Strom A, Papanas N,
Roden M and Ziegler D: Emerging biomarkers, tools, and treatments
for diabetic polyneuropathy. Endocr Rev. 40:153–192. 2019.
View Article : Google Scholar
|
|
60
|
Hammad SM, Baker NL, El Abiad JM,
Spassieva SD, Pierce JS, Rembiesa B, Bielawski J, Lopes-Virella MF
and Klein RL; DCCT/EDIC Group of Investigators: Increased plasma
levels of select deoxy-ceramide and ceramide species are associated
with increased odds of diabetic neuropathy in type 1 diabetes: A
pilot study. Neuromolecular Med. 19:46–56. 2017. View Article : Google Scholar :
|
|
61
|
Strain WD and Paldánius PM: Diabetes,
cardiovascular disease and the microcirculation. Cardiovasc
Diabetol. 17:572018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Criqui MH, Matsushita K, Aboyans V, Hess
CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F; American
Heart Association Council on Epidemiology and Prevention; et al:
Lower extremity peripheral artery disease: Contemporary
epidemiology, management gaps, and future directions: A scientific
statement from the american heart association. Circulation. 144.
pp. e171–e191. 2021, View Article : Google Scholar
|
|
63
|
He X and Schuchman EH: Ceramide and
ischemia/reperfusion injury. J Lipids. 2018:36467252018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Davis FM, Kimball A, Boniakowski A and
Gallagher K: Dysfunctional wound healing in diabetic foot ulcers:
New crossroads. Curr Diab Rep. 18:22018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Sloan G, Selvarajah D and Tesfaye S:
Pathogenesis, diagnosis and clinical management of diabetic
sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 17:400–420.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zweier JL and Ilangovan G: Regulation of
nitric oxide metabolism and vascular tone by cytoglobin. Antioxid
Redox Signal. 32:1172–1187. 2020. View Article : Google Scholar :
|
|
67
|
Sun HJ, Wu ZY, Nie XW and Bian JS: Role of
endothelial dysfunction in cardiovascular diseases: The link
between inflammation and hydrogen sulfide. Front Pharmacol.
10:15682020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chabowski DS, Cohen KE, Abu-Hatoum O,
Gutterman DD and Freed JK: Crossing signals: Bioactive lipids in
the microvasculature. Am J Physiol Heart Circ Physiol.
318:H1185–H1197. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhang QJ, Holland WL, Wilson L, Tanner JM,
Kearns D, Cahoon JM, Pettey D, Losee J, Duncan B, Gale D, et al:
Ceramide mediates vascular dysfunction in diet-induced obesity by
PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes.
61:1848–1859. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Akawi N, Checa A, Antonopoulos AS,
Akoumianakis I, Daskalaki E, Kotanidis CP, Kondo H, Lee K,
Yesilyurt D, Badi I, et al: Fat-secreted ceramides regulate
vascular redox state and influence outcomes in patients with
cardiovascular disease. J Am Coll Cardiol. 77:2494–2513. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Akhiyat N, Vasile V, Ahmad A, Sara JD,
Nardi V, Lerman LO, Jaffe A and Lerman A: Plasma ceramide levels
are elevated in patients with early coronary atherosclerosis and
endothelial dysfunction. J Am Heart Assoc. 11:e0228522022.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Karakashian AA, Giltiay NV, Smith GM and
Nikolova-Karakashian MN: Expression of neutral sphingomyelinase-2
(NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK
activation. FASEB J. 18:968–970. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Parker BA, Walton CM, Carr ST, Andrus JL,
Cheung ECK, Duplisea MJ, Wilson EK, Draney C, Lathen DR, Kenner KB,
et al: β-Hydroxybutyrate elicits favorable mitochondrial changes in
skeletal muscle. Int J Mol Sci. 19:22472018. View Article : Google Scholar
|
|
74
|
Cogolludo A, Villamor E, Perez-Vizcaino F
and Moreno L: Ceramide and regulation of vascular tone. Int J Mol
Sci. 20:4112019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sletten AC, Peterson LR and Schaffer JE:
Manifestations and mechanisms of myocardial lipotoxicity in
obesity. J Intern Med. 284:478–491. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Arsenault EJ, McGill CM and Barth BM:
Sphingolipids as regulators of neuro-inflammation and NADPH oxidase
2. Neuromolecular Med. 23:25–46. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Patwardhan GA, Beverly LJ and Siskind LJ:
Sphingolipids and mitochondrial apoptosis. J Bioenerg Biomembr.
48:153–168. 2016. View Article : Google Scholar
|
|
78
|
Colombini M: Ceramide channels and
mitochondrial outer membrane permeability. J Bioenerg Biomembr.
49:57–64. 2017. View Article : Google Scholar
|
|
79
|
Cantalupo A, Sasset L, Gargiulo A,
Rubinelli L, Del Gaudio I, Benvenuto D, Wadsack C, Jiang XC, Bucci
MR and Di Lorenzo A: Endothelial sphingolipid de novo synthesis
controls blood pressure by regulating signal transduction and NO
via ceramide. Hypertension. 75:1279–1288. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Pérez-Villavicencio R, Flores-Estrada J,
Franco M, Escalante B, Pérez-Méndez O, Mercado A and Bautista-Pérez
R: Effect of empagliflozin on sphingolipid catabolism in diabetic
and hypertensive rats. Int J Mol Sci. 23:28832022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lin YH, Jewell BE, Gingold J, Lu L, Zhao
R, Wang LL and Lee DF: Osteosarcoma: Molecular pathogenesis and
iPSC modeling. Trends Mol Med. 23:737–755. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Altura BM, Gebrewold A, Carella A, Shah
NC, Shah GJ, Resnick LM and Altura BT: Why vasculitis probably can
be ameliorated with magnesium and antagonists of ceramides and
platelet-activating factor. MOJ Anat Physiol. 6:120–123. 2019.
|
|
83
|
Borodzicz-Jażdżyk S, Jażdżyk P, Łysik W,
Cudnoch-Jedrzejewska A and Czarzasta K: Sphingolipid metabolism and
signaling in cardiovascular diseases. Front Cardiovasc Med.
9:9159612022. View Article : Google Scholar
|
|
84
|
Zhang Y, Zhao H, Liu B, Shu H, Zhang L,
Bao M, Yi W, Tan Y, Ji X, Zhang C, et al: Human serum metabolomic
analysis reveals progression for high blood pressure in type 2
diabetes mellitus. BMJ Open Diabetes Res Care. 9:e0023372021.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Li X, Wang HF, Li XX and Xu M:
Contribution of acid sphingomyelinase to angiotensin II-induced
vascular adventitial remodeling via membrane rafts/Nox2 signal
pathway. Life Sci. 219:303–310. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Liu A, Chu YJ, Wang X, Yu R, Jiang H, Li
Y, Zhou H, Gong LL, Yang WQ and Ju J: Serum metabolomics study
based on LC-MS and antihypertensive effect of uncaria on
spontaneously hypertensive rats. Evid Based Complement Alternat
Med. 2018:92819462018. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Shu H, Peng Y, Hang W, Li N, Zhou N and
Wang DW: Emerging roles of ceramide in cardiovascular diseases.
Aging Dis. 13:232–245. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Choi SR, Lim JH, Kim MY, Kim EN, Kim Y,
Choi BS, Kim YS, Kim HW, Lim KM, Kim MJ and Park CW: Adiponectin
receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and
ameliorated diabetic nephropathy. Metabolism. 85:348–360. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yaribeygi H, Bo S, Ruscica M and Sahebkar
A: Ceramides and diabetes mellitus: An update on the potential
molecular relationships. Diabet Med. 37:11–19. 2020. View Article : Google Scholar
|
|
90
|
Kane JP, Pullinger CR, Goldfine ID and
Malloy MJ: Dyslipidemia and diabetes mellitus: Role of lipoprotein
species and inter-related pathways of lipid metabolism in diabetes
mellitus. Curr Opin Pharmacol. 61:21–27. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Guitton J, Bandet CL, Mariko ML, Tan-Chen
S, Bourron O, Benomar Y, Hajduch E and Le Stunff H:
Sphingosine-1-phosphate metabolism in the regulation of
obesity/type 2 diabetes. Cells. 9:16822020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Miller LG Jr, Young JA, Ray SK, Wang G,
Purohit S, Banik NL and Dasgupta S: Sphingosine toxicity in EAE and
MS: Evidence for ceramide generation via
serine-palmitoyltransferase activation. Neurochem Res.
42:2755–2768. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Siskind LJ: Mitochondrial ceramide and the
induction of apoptosis. J Bioenerg Biomembr. 37:143–153. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Mancini A, Imperlini E, Nigro E,
Montagnese C, Daniele A, Orrù S and Buono P: Biological and
nutritional properties of palm oil and palmitic acid: Effects on
health. Molecules. 20:17339–17361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Park IB, Kim MH, Han JS and Park WJ:
Gryllus bimaculatus extract protects against palmitate-induced
β-cell death by inhibiting ceramide synthesis. Appl Biol Chem.
65:722022. View Article : Google Scholar
|
|
96
|
Tong X, Chaudhry Z, Lee CC, Bone RN,
Kanojia S, Maddatu J, Sohn P, Weaver SA, Robertson MA, Petrache I,
et al: Cigarette smoke exposure impairs β-cell function through
activation of oxidative stress and ceramide accumulation. Mol
Metab. 37:1009752020. View Article : Google Scholar
|
|
97
|
Xu YN, Wang Z, Zhang SK, Xu JR, Pan ZX,
Wei X, Wen HH, Luo YS, Guo MJ and Zhu Q: Low-grade elevation of
palmitate and lipopolysaccharide synergistically induced β-cell
damage via inhibition of neutral ceramidase. Mol Cell Endocrinol.
539:1114732022. View Article : Google Scholar
|
|
98
|
Šrámek J, Němcová-Fürstová V and Kovář J:
Molecular mechanisms of apoptosis induction and its regulation by
fatty acids in pancreatic β-cells. Int J Mol Sci. 22:42852021.
View Article : Google Scholar
|
|
99
|
Canals D, Salamone S and Hannun YA:
Visualizing bioactive ceramides. Chem Phys Lipids. 216:142–151.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Marra F and Svegliati-Baroni G:
Lipotoxicity and the gut-liver axis in NASH pathogenesis. J
Hepatol. 68:280–295. 2018. View Article : Google Scholar
|
|
101
|
Meikle PJ and Summers SA: Sphingolipids
and phospholipids in insulin resistance and related metabolic
disorders. Nat Rev Endocrinol. 13:79–91. 2017. View Article : Google Scholar
|
|
102
|
Bandet CL, Tan-Chen S, Bourron O, Stunff
HL and Hajduch E: Sphingolipid metabolism: New insight into
ceramide-induced lipotoxicity in muscle cells. Int J Mol Sci.
20:4792019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Fang Z, Pyne S and Pyne NJ: Ceramide and
sphingosine 1-phosphate in adipose dysfunction. Prog Lipid Res.
74:145–159. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Bekhite M, González-Delgado A, Hübner S,
Haxhikadrija P, Kretzschmar T, Müller T, Wu JMF, Bekfani T, Franz
M, Wartenberg M, et al: The role of ceramide accumulation in human
induced pluripotent stem cell-derived cardiomyocytes on
mitochondrial oxidative stress and mitophagy. Free Radic Biol Med.
167:66–80. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Chavez JA, Knotts TA, Wang LP, Li G,
Dobrowsky RT, Florant GL and Summers SA: A role for ceramide, but
not diacylglycerol, in the antagonism of insulin signal
transduction by saturated fatty acids. J Biol Chem.
278:10297–10303. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zalewska A, Maciejczyk M, Szulimowska J,
Imierska M and Błachnio-Zabielska A: High-fat diet affects ceramide
content, disturbs mitochondrial redox balance, and induces
apoptosis in the submandibular glands of mice. Biomolecules.
9:8772019. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Holland WL, Brozinick JT, Wang LP, Hawkins
ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, et
al: Inhibition of ceramide synthesis ameliorates glucocorticoid-,
saturated-fat-, and obesity-induced insulin resistance. Cell Metab.
5:167–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Petersen MC and Shulman GI: Mechanisms of
insulin action and insulin resistance. Physiol Rev. 98:2133–2223.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Gasparini SJ, Swarbrick MM, Kim S, Thai
LJ, Henneicke H, Cavanagh LL, Tu J, Weber MC, Zhou H and Seibel MJ:
Androgens sensitise mice to glucocorticoid-induced insulin
resistance and fat accumulation. Diabetologia. 62:1463–1477. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Linn SC, Kim HS, Keane EM, Andras LM, Wang
E and Merrill AH Jr: Regulation of de novo sphingolipid
biosynthesis and the toxic consequences of its disruption. Biochem
Soc Trans. 29:831–835. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Choi KM, Lee YS, Choi MH, Sin DM, Lee S,
Ji SY, Lee MK, Lee YM, Yun YP, Hong JT and Yoo HS: Inverse
relationship between adipocyte differentiation and ceramide level
in 3T3-L1 cells. Biol Pharm Bull. 34:912–916. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Li Y, Talbot CL, Chandravanshi B, Ksiazek
A, Sood A, Chowdhury KH, Maschek JA, Cox J, Babu AKS, Paz HA, et
al: Cordyceps inhibits ceramide biosynthesis and improves insulin
resistance and hepatic steatosis. Sci Rep. 12:72732022. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Kumar DP, Caffrey R, Marioneaux J,
Santhekadur PK, Bhat M, Alonso C, Koduru SV, Philip B, Jain MR,
Giri SR, et al: The PPAR α/γ agonist saroglitazar improves insulin
resistance and steatohepatitis in a diet induced animal model of
nonalcoholic fatty liver disease. Sci Rep. 10:93302020. View Article : Google Scholar
|
|
114
|
Kucuk S, Niven J, Caamano J, Jones SW,
Camacho-Muñoz D, Nicolaou A and Mauro C: Unwrapping the mechanisms
of ceramide and fatty acid-initiated signals leading to
immune-inflammatory responses in obesity. Int J Biochem Cell Biol.
135:1059722021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Gilbert M: Role of skeletal muscle lipids
in the pathogenesis of insulin resistance of obesity and type 2
diabetes. J Diabetes Investig. 12:1934–1941. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Reidy PT, Mahmassani ZS, McKenzie AI,
Petrocelli JJ, Summers SA and Drummond MJ: Influence of exercise
training on skeletal muscle insulin resistance in aging: Spotlight
on muscle ceramides. Int J Mol Sci. 21:15142020. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Coen PM and Goodpaster BH: Role of
intramyocelluar lipids in human health. Trends Endocrinol Metab.
23:391–398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Galadari S, Rahman A, Pallichankandy S,
Galadari A and Thayyullathil F: Role of ceramide in diabetes
mellitus: Evidence and mechanisms. Lipids Health Dis. 12:982013.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Choi RH, Tatum SM, Symons JD, Summers SA
and Holland WL: Ceramides and other sphingolipids as drivers of
cardiovascular disease. Nat Rev Cardiol. 18:701–711. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Edsfeldt A, Dunér P, Ståhlman M, Mollet
IG, Asciutto G, Grufman AHM, Nitulescu M, Persson AF, Fisher RM,
Melander O, et al: Proinflammatory role of sphingolipids and
glycosphingolipids in the human atherosclerotic plaque.
Arterioscler Thromb Vasc Biol. 36:1132–1140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Wang P, Zeng G, Yan Y, Zhang SY, Dong Y,
Zhang Y, Zhang X, Liu H, Zhang Z, Jiang C and Pang Y: Disruption of
adipocyte HIF-1 α improves atherosclerosis through the inhibition
of ceramide generation. Acta Pharm Sin B. 12:1899–1912. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Yang RX, Pan Q, Liu XL, Zhou D, Xin FZ,
Zhao ZH, Zhang RN, Zeng J, Qiao L, Hu CX, et al: Therapeutic effect
and autophagy regulation of myriocin in nonalcoholic
steatohepatitis. Lipids Health Dis. 18:1792019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhang X, Zhang Y, Wang P, Zhang SY, Dong
Y, Zeng G, Yan Y, Sun L, Wu Q, Liu H, et al: Adipocyte
hypoxia-inducible factor 2α suppresses atherosclerosis by promoting
adipose ceramide catabolism. Cell Metab. 30:937–951.e5. 2019.
View Article : Google Scholar
|
|
124
|
Dany M, Gencer S, Nganga R, Thomas RJ,
Oleinik N, Baron KD, Szulc ZM, Ruvolo P, Kornblau S, Andreeff M and
Ogretmen B: Targeting FLT3-ITD signaling mediates
ceramide-dependent mitophagy and attenuates drug resistance in AML.
Blood. 128:1944–1958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zhang Y, Huang NQ, Yan F, Jin H, Zhou SY,
Shi JS and Jin F: Diabetes mellitus and Alzheimer's disease: GSK-3β
as a potential link. Behav Brain Res. 339:57–65. 2018. View Article : Google Scholar
|
|
126
|
Yang Y, Xu G, Xu Y, Cheng X, Xu S, Chen S
and Wu L: Ceramide mediates radiation-induced germ cell apoptosis
via regulating mitochondria function and MAPK factors in
caenorhabditis elegans. Ecotoxicol Environ Saf. 208:1115792021.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Ganesan V, Perera MN, Colombini D,
Datskovskiy D, Chadha K and Colombini M: Ceramide and activated Bax
act synergistically to permeabilize the mitochondrial outer
membrane. Apoptosis. 15:553–562. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
James BN, Oyeniran C, Sturgill JL, Newton
J, Martin RK, Bieberich E, Weigel C, Maczis MA, Palladino END,
Lownik JC, et al: Ceramide in apoptosis and oxidative stress in
allergic inflammation and asthma. J Allergy Clin Immunol.
147:1936–1948.e9. 2021. View Article : Google Scholar :
|
|
129
|
Römer A, Linn T and Petry SF: Lipotoxic
impairment of mitochondrial function in β-cells: A review.
Antioxidants (Basel). 10:2932021. View Article : Google Scholar
|
|
130
|
Onyango AN: Cellular stresses and stress
responses in the pathogenesis of insulin resistance. Oxid Med Cell
Longev. 2018:43217142018. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Ueda N: A rheostat of ceramide and
sphingosine-1-phosphate as a determinant of oxidative
stress-mediated kidney injury. Int J Mol Sci. 23:40102022.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Poole LP and Macleod KF: Mitophagy in
tumorigenesis and metastasis. Cell Mol Life Sci. 78:3817–3851.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Srivastava S and Chan C: Hydrogen peroxide
and hydroxyl radicals mediate palmitate-induced cytotoxicity to
hepatoma cells: Relation to mitochondrial permeability transition.
Free Radic Res. 41:38–49. 2007. View Article : Google Scholar
|
|
134
|
Law BA, Liao X, Moore KS, Southard A,
Roddy P, Ji R, Szulc Z, Bielawska A, Schulze PC and Cowart LA:
Lipotoxic very-long-chain ceramides cause mitochondrial
dysfunction, oxidative stress, and cell death in cardiomyocytes.
FASEB J. 32:1403–1416. 2018. View Article : Google Scholar :
|
|
135
|
Botta A, Elizbaryan K, Tashakorinia P, Lam
NH and Sweeney G: An adiponectin-S1P autocrine axis protects
skeletal muscle cells from palmitate-induced cell death. Lipids
Health Dis. 19:1562020. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Simon JN, Chowdhury SAK, Warren CM,
Sadayappan S, Wieczorek DF, Solaro RJ and Wolska BM:
Ceramide-mediated depression in cardiomyocyte contractility through
PKC activation and modulation of myofilament protein
phosphorylation. Basic Res Cardiol. 109:4452014. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Kim C and Kim B: Anti-cancer natural
products and their bioactive compounds inducing ER stress-mediated
apoptosis: A review. Nutrients. 10:10212018. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Hu H, Tian M, Ding C and Yu S: The C/EBP
homologous protein (CHOP) transcription factor functions in
endoplasmic reticulum stress-induced apoptosis and microbial
infection. Front Immunol. 9:30832019. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Xiang C, Wang Y, Zhang H and Han F: The
role of endoplasmic reticulum stress in neurodegenerative disease.
Apoptosis. 22:1–26. 2017. View Article : Google Scholar
|
|
140
|
Szpigel A, Hainault I, Carlier A,
Venteclef N, Batto AF, Hajduch E, Bernard C, Ktorza A, Gautier JF,
Ferré P, et al: Lipid environment induces ER stress, TXNIP
expression and inflammation in immune cells of individuals with
type 2 diabetes. Diabetologia. 61:399–412. 2018. View Article : Google Scholar
|
|
141
|
Xu G, Chen J, Jing G, Grayson TB and
Shalev A: miR-204 targets PERK and regulates UPR signaling and
β-cell apoptosis. Mol Endocrinol. 30:917–924. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Ojo OA, Grant S, Amanze JC, Oni AI, Ojo
AB, Elebiyo TC, Obafemi TO, Ayokunle DI and Ogunlakin AD: Annona
muricata L. peel extract inhibits carbohydrate metabolizing enzymes
and reduces pancreatic β-cells, inflammation, and apoptosis via
upregulation of PI3K/AKT genes. PLoS One. 17:e02769842022.
View Article : Google Scholar
|
|
143
|
Wang Y, Liu J, Akatsu C, Zhang R, Zhang H,
Zhu H, Liu K, Zhu HY, Min Q, Meng X, et al: LAPTM5 mediates
immature B cell apoptosis and B cell tolerance by regulating the
WWP2-PTEN-AKT pathway. Proc Natl Acad Sci USA. 119:e22056291192022.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Hsu CM, Lin JJ, Su JH and Liu CI:
13-Acetoxysarcocrassolide induces apoptosis in human hepatocellular
carcinoma cells through mitochondrial dysfunction and suppression
of the PI3K/AKT/mTOR/p70S6K signalling pathway. Pharm Biol.
60:2276–2285. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Cui F and He X: IGF-1 ameliorates
streptozotocin-induced pancreatic β cell dysfunction and apoptosis
via activating IRS1/PI3K/Akt/FOXO1 pathway. Inflamm Res.
71:669–680. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Denhez B, Rousseau M, Spino C, Dancosst
DA, Dumas MÈ, Guay A, Lizotte F and Geraldes P: Saturated fatty
acids induce insulin resistance in podocytes through inhibition of
IRS1 via activation of both IKKβ and mTORC1. Sci Rep. 10:216282020.
View Article : Google Scholar
|
|
147
|
Jennemann R, Kaden S, Volz M, Nordström V,
Herzer S, Sandhoff R and Gröne HJ: Gangliosides modulate insulin
secretion by pancreatic beta cells under glucose stress.
Glycobiology. 30:722–734. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Benito-Vicente A, Jebari-Benslaiman S,
Galicia-Garcia U, Larrea-Sebal A, Uribe KB and Martin C: Molecular
mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction.
Int Rev Cell Mol Biol. 359:357–402. 2021. View Article : Google Scholar
|
|
149
|
Huang X, Liu G, Guo J and Su Z: The
PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci.
14:1483–1496. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Obanda DN, Ribnicky D, Yu Y, Stephens J
and Cefalu WT: An extract of Urtica dioica L. mitigates obesity
induced insulin resistance in mice skeletal muscle via protein
phosphatase 2A (PP2A). Sci Rep. 6:222222016. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Li J, Huang J, Lu J, Guo Z, Li Z, Gao H,
Wang P, Luo W, Cai S, Hu Y, et al: Sirtuin 1 represses PKC-ζ
activity through regulating interplay of acetylation and
phosphorylation in cardiac hypertrophy. Br J Pharmacol.
176:416–435. 2019.
|
|
152
|
Ivey RA, Sajan MP and Farese RV:
Requirements for pseudosubstrate arginine residues during
autoinhibition and phosphatidylinositol 3,4,5-(PO4)3-dependent
activation of atypical PKC. J Biol Chem. 289:25021–25030. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Campana M, Bellini L, Rouch C, Rachdi L,
Coant N, Butin N, Bandet CL, Philippe E, Meneyrol K, Kassis N, et
al: Inhibition of central de novo ceramide synthesis restores
insulin signaling in hypothalamus and enhances β-cell function of
obese Zucker rats. Mol Metab. 8:23–36. 2018. View Article : Google Scholar
|
|
154
|
Wali JA, Jarzebska N, Raubenheimer D,
Simpson SJ, Rodionov RN and O'Sullivan JF: Cardio-metabolic effects
of high-fat diets and their underlying mechanisms-a narrative
review. Nutrients. 12:15052020. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Huang H, Aminian A, Hassan M, Dan O,
Axelrod CL, Schauer PR, Brethauer SA and Kirwan JP: Gastric bypass
surgery improves the skeletal muscle ceramide/S1P ratio and
upregulates the AMPK/SIRT1/PGC-1α pathway in Zucker diabetic fatty
rats. Obes Surg. 29:2158–2165. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Matsuzaka T, Kuba M, Koyasu S, Yamamoto Y,
Motomura K, Arulmozhiraja S, Ohno H, Sharma R, Shimura T, Okajima
Y, et al: Hepatocyte ELOVL fatty acid elongase 6 determines
ceramide Acyl-chain length and hepatic insulin sensitivity in mice.
Hepatology. 71:1609–1625. 2020. View Article : Google Scholar
|
|
157
|
Yazıcı D and Sezer H: Insulin resistance,
obesity and lipotoxicity. Engin AB and Engin A: Obesity and
Lipotoxicity. Advances in Experimental Medicine and Biology. 960.
Springer International Publishing; pp. 277–304. 2017, View Article : Google Scholar
|
|
158
|
Xia QS, Lu FE, Wu F, Huang ZY, Dong H, Xu
LJ and Gong J: New role for ceramide in hypoxia and insulin
resistance. World J Gastroenterol. 26:2177–2186. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Obata Y, Kita S, Koyama Y, Fukuda S,
Takeda H, Takahashi M, Fujishima Y, Nagao H, Masuda S, Tanaka Y, et
al: Adiponectin/T-cadherin system enhances exosome biogenesis and
decreases cellular ceramides by exosomal release. JCI Insight.
3:e996802018. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Santovito D, De Nardis V, Marcantonio P,
Mandolini C, Paganelli C, Vitale E, Buttitta F, Bucci M, Mezzetti
A, Consoli A and Cipollone F: Plasma exosome microRNA profiling
unravels a new potential modulator of adiponectin pathway in
diabetes: Effect of glycemic control. J Clin Endocrinol Metab.
99:E1681–E1685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Ying W, Riopel M, Bandyopadhyay G, Dong Y,
Birmingham A, Seo JB, Ofrecio JM, Wollam J, Hernandez-Carretero A,
Fu W, et al: Adipose tissue macrophage-derived exosomal miRNAs can
modulate in vivo and in vitro insulin sensitivity. Cell.
171:372–384.e12. 2017. View Article : Google Scholar
|
|
162
|
Tian F, Tang P, Sun Z, Zhang R, Zhu D, He
J, Liao J, Wan Q and Shen J: miR-210 in exosomes derived from
macrophages under high glucose promotes mouse diabetic obesity
pathogenesis by suppressing NDUFA4 expression. J Diabetes Res.
2020:68946842020. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Ruiz-León AM, Lapuente M, Estruch R and
Casas R: Clinical advances in immunonutrition and atherosclerosis:
A review. Front Immunol. 10:8372019. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Geovanini GR and Libby P: Atherosclerosis
and inflammation: Overview and updates. Clin Sci (Lond).
132:1243–1252. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Ho QWC, Zheng X and Ali Y: Ceramide Acyl
chain length and its relevance to intracellular lipid regulation.
Int J Mol Sci. 23:96972022. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Sindhu S, Leung YH, Arefanian H, Madiraju
SRM, Al-Mulla F, Ahmad R and Prentki M: Neutral sphingomyelinase-2
and cardiometabolic diseases. Obes Rev. 22:e132482021. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Chen X, Guo X, Ge Q, Zhao Y, Mu H and
Zhang J: ER stress activates the NLRP3 inflammasome: A novel
mechanism of atherosclerosis. Oxid Med Cell Longev.
2019:34625302019. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Alaaeldin R, Abdel-Rahman IAM, Hassan HA,
Youssef N, Allam AE, Abdelwahab SF, Zhao QL and Fathy M:
Carpachromene ameliorates insulin resistance in HepG2 cells via
modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 pathway. Molecules.
26:76292021. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Gündüz D, Troidl C, Tanislav C, Rohrbach
S, Hamm C and Aslam M: Role of PI3K/Akt and MEK/ERK signalling in
cAMP/Epac-mediated endothelial barrier stabilisation. Front
Physiol. 10:13872019. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Prasad M, Gatasheh MK, Alshuniaber MA,
Krishnamoorthy R, Rajagopal P, K rishnamoor thy K, Periyasamy V,
Veeraraghavan VP and Jayaraman S: Impact of glyphosate on the
development of insulin resistance in experimental diabetic rats:
Role of NFκB signalling pathways. Antioxidants (Basel).
11:24362022. View Article : Google Scholar
|
|
171
|
Wright CJ, McKenna S, De Dios R, Boehmer
BH, Nguyen L, Ghosh S, Sandoval J and Rozance PJ: Lower threshold
to NFκB activity sensitizes murine β-cells to streptozotocin. J
Endocrinol. 249:163–175. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Lin Z, Ge J, Wang Z, Ren J, Wang X, Xiong
H, Gao J, Zhang Y and Zhang Q: Let-7e modulates the inflammatory
response in vascular endothelial cells through ceRNA crosstalk. Sci
Rep. 7:424982017. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Olona A, Hateley C, Muralidharan S, Wenk
MR, Torta F and Behmoaras J: Sphingolipid metabolism during
Toll-like receptor 4 (TLR4)-mediated macrophage activation. Br J
Pharmacol. 178:4575–4587. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Engin A: The pathogenesis of
obesity-associated adipose tissue inflammation. Obesity and
Lipotoxicity. Advances in Experimental Medicine and Biology. Engin
AB and Engin A: 960. Springer International Publishing; pp.
221–245. 2017, View Article : Google Scholar
|
|
175
|
Berg M, Polyzos KA, Agardh H, Baumgartner
R, Forteza MJ, Kareinen I, Gisterå A, Bottcher G, Hurt-Camejo E,
Hansson GK and Ketelhuth DFJ: 3-Hydroxyanthralinic acid metabolism
controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome
activation in macrophages, and decreases atherosclerosis in Ldlr-/-
mice. Cardiovasc Res. 116:1948–1957. 2020. View Article : Google Scholar
|
|
176
|
Hornemann T and Worgall TS: Sphingolipids
and atherosclerosis. Atherosclerosis. 226:16–28. 2013. View Article : Google Scholar
|
|
177
|
Dekker MJ, Baker C, Naples M, Samsoondar
J, Zhang R, Qiu W, Sacco J and Adeli K: Inhibition of sphingolipid
synthesis improves dyslipidemia in the diet-induced hamster model
of insulin resistance: Evidence for the role of sphingosine and
sphinganine in hepatic VLDL-apoB100 overproduction.
Atherosclerosis. 228:98–109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Yang J and Liu Z: Mechanistic pathogenesis
of endothelial dysfunction in diabetic nephropathy and retinopathy.
Front Endocrinol (Lausanne). 13:8164002022. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Sharma S, Schaper N and Rayman G:
Microangiopathy: Is it relevant to wound healing in diabetic foot
disease? Diabetes Metab Res Rev. 36(Suppl 1): e32442020. View Article : Google Scholar
|
|
180
|
Wang S, Lei B, Zhang E, Gong P, Gu J, He
L, Han L and Yuan Z: Targeted therapy for inflammatory diseases
with mesenchymal stem cells and their derived exosomes: From basic
to clinics. Int J Nanomedicine. 17:1757–1781. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Gil CL, Hooker E and Larrivée B: Diabetic
kidney disease, endothelial damage, and podocyte-endothelial
crosstalk. Kidney Med. 3:105–115. 2020. View Article : Google Scholar
|
|
182
|
Zhao WN, Xu SQ, Liang JF, Peng L, Liu HL,
Wang Z, Fang Q, Wang M, Yin WQ, Zhang WJ and Lou JN: Endothelial
progenitor cells from human fetal aorta cure diabetic foot in a rat
model. Metabolism. 65:1755–1767. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Basra R, Papanas N, Farrow F, Karalliedde
J and Vas P: Diabetic foot ulcers and cardiac autonomic neuropathy.
Clin Ther. 44:323–330. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
King RJ, Harrison L, Gilbey SG,
Santhakumar A, Wyatt J, Jones R and Bodansky HJ: Diabetic
hepatosclerosis: Another diabetes microvascular complication?
Diabet Med. 33:e5–e7. 2016. View Article : Google Scholar
|
